Author response to Comment on: Exploring the association between weight loss-inducing medications and multiple sclerosis: insights from the FDA adverse event reporting system database

Ther Adv Neurol Disord. 2024 Sep 17:17:17562864241276848. doi: 10.1177/17562864241276848. eCollection 2024.
No abstract available